NUCLEAR THERAPEUTICS HUB

Targeted Radiotherapies

Radionuclide Therapy

Explore the science and clinical application of targeted radionuclide therapies in modern oncology. Discover how radiopharmaceutical innovation enables personalised molecular treatment strategies.

Radiopharmaceuticals

Learn how radiolabelling, isotope selection and molecular targeting underpin effective nuclear therapeutics. Understand the translational pathway from laboratory development to regulated clinical delivery.

Precision Oncology

Contribute to advancing safe, research-informed nuclear therapeutics through collaboration and shared expertise. Support innovation that strengthens personalised treatment and improves patient outcomes.

Radiolabelling

Radiolabelling incorporates radioactive isotopes into molecules to trace biological processes and molecular pathways. This technique is used in drug development, metabolic research and translational nuclear medicine.

Radiotherapeutics

Radiotherapeutics uses targeted radionuclides such as actinium-225 to deliver cytotoxic radiation to malignant cells. This approach concentrates dose within tumours while limiting exposure to surrounding tissue.

Nuclear Medicine Lab With Isotopes Which Are Ready For Injection To Patient

Clinical Technologist

Clinical technologists prepare radiopharmaceuticals and operate nuclear medicine systems within regulated environments. They ensure protocol adherence, radiation safety and accurate delivery of diagnostic and therapeutic procedures.

Radiopharmaceuticals

Radiopharmaceuticals combine biologically active molecules with radioactive isotopes for imaging and therapy. Their clinical application requires strict manufacturing controls, regulatory oversight and quality assurance.

Radiopharmacy

Radiopharmacy oversees formulation, preparation and dispensing of radiopharmaceuticals for clinical use. Also, it integrates safety procedures, sterility standards and compliance within nuclear medicine services.

Radiotheranostics

Radiotheranostics links diagnostic imaging with targeted radionuclide therapy using related molecular agents. This approach enables patient selection, treatment planning and response assessment within precision oncology.

EXPLORE

Targeted Treatment

Radiotherapeutics deliver cytotoxic radiation directly to malignant cells using specialised radionuclides. This targeted strategy maximises tumour control while limiting exposure to surrounding healthy tissues

LEARN

Clinical Expertise

Clinical technologists and radiopharmacists ensure the safe preparation, regulatory compliance, and accurate dosing of radiopharmaceuticals. The aim is to maintain sterility standards and ensure reliable therapeutic delivery.

CONTRIBUTE

Theranostic Integration

Radiotheranostics unites diagnostic imaging with targeted therapy using biologically matched molecular agents. This integrated approach supports patient selection, response monitoring and adaptive precision oncology.